HeartBeam Joins European EXIT-CVD Consortium to Study At-Home ECG Monitoring
Bitget2026/10/15 12:32- HeartBeam joined the European EXIT-CVD research consortium, led by University Medical Center Groningen and Royal Philips.
- It will lead HEART-CHECK, evaluating at-home ECG monitoring for early detection and triage of cardiac events in high-risk patients discharged following ACS.
- Its contribution will be in-kind, including devices and clinical expertise.
- The EUR 27.6 million project is co-funded by the EU Innovative Health Initiative and industry partners, encompassing 22 studies involving over 14,000 patients.
- The system is FDA-cleared only for arrhythmia assessment; heart attack assessment remains investigational, and HEART-CHECK use will be investigational without CE marking.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.
Why Nintendo Stock Is One to Watch Ahead of the Holiday Season
A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.
Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.
Crypto prices
More
